4dmoleculartherapeutics.com Open in urlscan Pro
162.159.135.42  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Press Alt+1 for screen-reader mode, Alt+0 to cancelAccessibility Screen-Reader
Guide, Feedback, and Issue Reporting

 * Home
 * About
   * Our Approach
   * Guiding Principles
   * Leadership
   * Leadership in the News
   * Board of Directors
 * Technology
   * Platform
   * Product Engine
 * Pipeline
   * Pipeline
   * Clinical Candidates
 * Scientific Posters and Publications
 * Our Purpose
   * Ophthalmic Diseases
   * Pulmonary Diseases
   * Cardiology Diseases
 * Investors
 * Careers
   * Join our Team
   * Living our Guiding Principles
   * 4Diversity
   * What We Offer
   * Open Positions
 * Contact


 * Li.





 * Home
 * About
   * Our Approach
   * Guiding Principles
   * Leadership
   * Leadership in the News
   * Board of Directors
 * Technology
   * Platform
   * Product Engine
 * Pipeline
   * Pipeline
   * Clinical Candidates
 * Scientific Posters and Publications
 * Our Purpose
   * Ophthalmic Diseases
   * Pulmonary Diseases
   * Cardiology Diseases
 * Investors
 * Careers
   * Join our Team
   * Living our Guiding Principles
   * 4Diversity
   * What We Offer
   * Open Positions
 * Contact
 * Search
 * Menu Menu




POWERING THE FUTURE

Of Genetic Medicines





VISIONARY




UNCONSTRAINED BY NATURE



We are boldly innovating to unlock the full potential of genetic medicines for
large market diseases. We harness the power of directed evolution to invent
customized and enhanced vectors for use in our transformative products for
patients.

Our technology


EVOLVED




NEW ERA OF GENETIC MEDICINE



Driven by our innovative vector platform and efficient product design and
development engine, we are inventing and developing genetic medicines with
proprietary customized vectors that are optimized for the specific diseases we
treat. Our clinical product development programs are initially focused in
ophthalmology, pulmonology and cardiology.

Our pipeline


PATIENT-FOCUSED




GENETIC MEDICINES WITH CURATIVE INTENT



We partner with patient organizations, patients, their families and their
physicians to better understand their challenges and unmet needs. We integrate
this knowledge so we can continuously develop and improve our products as we
strive to provide transformative benefit for patients and potentially even
cures.

Our Purpose


CONTINUALLY BREAKING BOUNDARIES



Our exceptional team is committed to a culture that empowers the highest degree
of innovation, teamwork, preparation and execution excellence. We value and
cultivate internal and external collaborations. We seek to build diverse teams,
capabilities, product pipelines and business models.

Our Careers



NEWS & UPDATES




ASTELLAS EYES RARE OPHTHALMOLOGY, LICENSING 4DMT’S VIRAL VECTOR FOR GENE THERAPY
FOR UP TO $962M

September 22, 2023
July 10, 2023 | Endpoints
Read more

/wp-content/uploads/4dmt_logo.svg 0 0 Erik Allison
/wp-content/uploads/4dmt_logo.svg Erik Allison2023-09-22 08:00:252023-09-27
10:56:46Astellas eyes rare ophthalmology, licensing 4DMT’s viral vector for gene
therapy for up to $962M


ASTELLAS PAVES BACKLOADED BIOBUCKS DEAL TO TEST 4DMT’S EYE DISEASE GENE THERAPY
VECTOR

September 21, 2023
July 10, 2023 | Fierce Biotech
Read more

/wp-content/uploads/4dmt_logo.svg 0 0 Erik Allison
/wp-content/uploads/4dmt_logo.svg Erik Allison2023-09-21 08:00:332023-09-26
17:39:48Astellas paves backloaded biobucks deal to test 4DMT’s eye disease gene
therapy vector


4DMT’S INHALABLE GENE THERAPY FOR CYSTIC FIBROSIS SHOWS EARLY POSITIVE SIGNS IN
TINY GROUP OF PATIENTS

September 20, 2023
June 8, 2023 | Endpoints
Read more

/wp-content/uploads/4dmt_logo.svg 0 0 Erik Allison
/wp-content/uploads/4dmt_logo.svg Erik Allison2023-09-20 08:00:592023-09-26
17:40:534DMT’s inhalable gene therapy for cystic fibrosis shows early positive
signs in tiny group of patients


AEROW HITS THE MARK FOR 4D MOLECULAR

September 19, 2023
June 8, 2023 | Evaluate Vantage
Read more

/wp-content/uploads/4dmt_logo.svg 0 0 Erik Allison
/wp-content/uploads/4dmt_logo.svg Erik Allison2023-09-19 08:00:322023-09-26
17:41:08Aerow hits the mark for 4D Molecular


RECODE, VERTEX AND 4DMT SEEK TO HELP UNTREATED CYSTIC FIBROSIS PATIENTS

September 18, 2023
June 5, 2023 | BioSpace
Read more

/wp-content/uploads/4dmt_logo.svg 0 0 Erik Allison
/wp-content/uploads/4dmt_logo.svg Erik Allison2023-09-18 08:00:472023-09-26
17:41:19ReCode, Vertex and 4DMT Seek to Help Untreated Cystic Fibrosis Patients


5 GENE THERAPY COMPANIES THAT MAY TRANSFORM THE MEDICAL INDUSTRY

September 17, 2023
May 24, 2023 | NASDAQ
Read more

/wp-content/uploads/4dmt_logo.svg 0 0 Erik Allison
/wp-content/uploads/4dmt_logo.svg Erik Allison2023-09-17 08:00:562023-09-26
17:41:385 Gene Therapy Companies That May Transform the Medical Industry


4D MOLECULAR THERAPEUTICS ACQUIRES EYE DISEASE ASSET FROM FORTRESS BIOTECH
SUBSIDIARY

September 16, 2023
April 24, 2023 | Endpoints
Read more

/wp-content/uploads/4dmt_logo.svg 0 0 Erik Allison
/wp-content/uploads/4dmt_logo.svg Erik Allison2023-09-16 08:00:092023-09-26
17:41:504D Molecular Therapeutics acquires eye disease asset from Fortress
Biotech subsidiary


THEY WERE THE 10% LEFT OUT OF LIFE-CHANGING TREATMENTS. NOW THESE CYSTIC
FIBROSIS PATIENTS MAY FINALLY GET HELP

September 15, 2023
Feb 3, 2023 | STAT
Read more

/wp-content/uploads/4dmt_logo.svg 0 0 Erik Allison
/wp-content/uploads/4dmt_logo.svg Erik Allison2023-09-15 08:00:002023-09-26
17:42:05They were the 10% left out of life-changing treatments. Now these cystic
fibrosis patients may finally get help


#NACFC2022 – 4D-710 SAFE, RESTORES CFTR LUNG PRODUCTION IN 3 PATIENTS

September 14, 2023
November 8, 2022 | Cystic Fibrosis News Today
Read more

/wp-content/uploads/4dmt_logo.svg 0 0 Erik Allison
/wp-content/uploads/4dmt_logo.svg Erik Allison2023-09-14 08:00:582023-09-26
17:42:18#NACFC2022 – 4D-710 Safe, Restores CFTR Lung Production in 3 Patients
View More
Press Releases


ABOUT 4DMT




Our 4DMT genetic medicine engine holds the potential to generate transformative
therapies that have the power to improve patient lives, or even cure disease.


NAVIGATION



 * Home
 * About
   * Our Approach
   * Guiding Principles
   * Leadership
   * Leadership in the News
   * Board of Directors
 * Technology
   * Platform
   * Product Engine
 * Pipeline
   * Pipeline
   * Clinical Candidates
 * Scientific Posters and Publications
 * Our Purpose
   * Ophthalmic Diseases
   * Pulmonary Diseases
   * Cardiology Diseases
 * Investors
 * Careers
   * Join our Team
   * Living our Guiding Principles
   * 4Diversity
   * What We Offer
   * Open Positions
 * Contact


LOCATION




5858 Horton St. Suite 455
Emeryville, CA 94608

(510) 505-2680
info@4dmt.com

© 2023 4D Molecular Therapeutics. All rights reserved.

 * Contact
 * Privacy Policy
 * Site Terms
 * 

Scroll to top


This site uses cookies. By continuing to browse the site, you are agreeing to
our use of cookies.

Accept settingsHide notification onlySettings


COOKIE AND PRIVACY SETTINGS





How we use cookies
Essential Website Cookies
Google Analytics Cookies
Other external services
Privacy Policy
How we use cookies

We may request cookies to be set on your device. We use cookies to let us know
when you visit our websites, how you interact with us, to enrich your user
experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change
some of your preferences. Note that blocking some types of cookies may impact
your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available
through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing
them will have impact how our site functions. You always can block or delete
cookies by changing your browser settings and force blocking all cookies on this
website. But this will always prompt you to accept/refuse cookies when
revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and
again kindly allow us to store a cookie for that. You are free to opt out any
time or opt in for other cookies to get a better experience. If you refuse
cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so
you can check what we stored. Due to security reasons we are not able to show or
modify cookies from other domains. You can check these in your browser security
settings.

Check to enable permanent hiding of message bar and refuse all cookies if you do
not opt in. We need 2 cookies to store this setting. Otherwise you will be
prompted again when opening a new browser window or new a tab.
Click to enable/disable essential site cookies.
Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help
us understand how our website is being used or how effective our marketing
campaigns are, or to help us customize our website and application for you in
order to enhance your experience.

If you do not want that we track your visit to our site you can disable tracking
in your browser here:

Click to enable/disable Google Analytics tracking.
Other external services

We also use different external services like Google Webfonts, Google Maps, and
external Video providers. Since these providers may collect personal data like
your IP address we allow you to block them here. Please be aware that this might
heavily reduce the functionality and appearance of our site. Changes will take
effect once you reload the page.

Google Webfont Settings:

Click to enable/disable Google Webfonts.

Google Map Settings:

Click to enable/disable Google Maps.

Google reCaptcha Settings:

Click to enable/disable Google reCaptcha.

Vimeo and Youtube video embeds:

Click to enable/disable video embeds.
Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy
Policy Page.

Accept settingsHide notification only